![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 31/517 | |
A61P 35/00 |
(11) | Patento numeris | 2303276 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 09746098.4 |
Europos patento paraiškos padavimo data | 2009-05-11 | |
(97) | Europos patento paraiškos paskelbimo data | 2011-04-06 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2013-11-13 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/GB2009/050496 |
Data | 2009-05-11 |
(87) | Numeris | WO 2009/138781 |
Data | 2009-11-19 |
(30) | Numeris | Data | Šalis |
52706 P | 2008-05-13 | US | |
110637 P | 2008-11-03 | US |
(72) |
BOARDMAN, Kay, Alison, GB
HARD, Susan, Elizabeth, GB
DOBSON, Andrew, Hornby, GB
WHITLOCK, Brian, GB
|
(73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
(54) | FUMARATE SALT OF 4-(3-CHLORO-2-FLUOROANILINO)-7-METHOXY-6-{[1-(N-METHYLCARBAMOYLMETHYL)PIPERIDIN-4-YL]OXY}QUINAZOLINE |
FUMARATE SALT OF 4-(3-CHLORO-2-FLUOROANILINO)-7-METHOXY-6-{[1-(N-METHYLCARBAMOYLMETHYL)PIPERIDIN-4-YL]OXY}QUINAZOLINE |